HCI Group Becomes First HIMSS EMRAM Global Education and Certification Provider

Published on:

Jacksonville, Florida, February 16, 2016 -- The HCI Group [HCI], an industry-leading healthcare IT services consultancy, today announced its partnership with HIMSS to become the organization’s first official Electronic Medical Record Adoption Model [EMRAM] Global Education provider.

HIMSS Analytics has been providing maturity models for more than 10 years, focusing on important areas of healthcare advancement including the Electronic Medical Record Adoption Model, or EMRAM. The EMRAM model is used globally as a measurement of the maturity of healthcare facilities as they leverage technology to improve the quality of healthcare.

As a HIMSS global EMRAM Education partner, HCI will provide client education and consulting to improve EMR Adoption Model scores and prepare those clients for HIMSS Analytics validation as Stage 6 and Stage 7 organizations on the world scale.

“Embarking on this educator program partnership will help HCI further our mission of being the global leader in healthcare technology consulting,” said Ricky Caplin, CEO, the HCI Group. “It also allows us to become expert partners with HIMSS Analytics and support the values brought by EMR adoption.”

Addressing a group of attendees at the recent HIMSS AsiaPac 15, HCI, along with John P. Hoyt, Executive Vice President, HIMSS Analytics, presented “The Value of Partnerships for EMRAM Growth,” which focused on the views of successful methodologies for enterprise cultural transformation leveraging technology, using EMRAM as a guide.

“The Certified Educator program is a part of HIMSS Analytics global strategic initiatives,” noted Stephen Lieber, President and CEO, HIMSS. “HCI Group’s recent certification is an example of how HIMSS Analytics works with key stakeholders and influencers within healthcare to bring greater awareness to the impact and value of IT.”

“Leveraging an EMR, whether you buy or build, is more than just getting rid of the paper; it is a cultural paradigm shift and a transformation of care,” added Anthony Binge, International Managing Director, the HCI Groups. “Technology is but an enabler; to be successful you must truly grasp the organizational and cultural change that needs to take place through every level of every department.”

About HIMSS Analytics

HIMSS Analytics is a global healthcare advisor, providing guidance and market intelligence solutions that move the industry forward with insight to enable better health through the use of IT.  As a trusted healthcare research and advisory firm, the industry depends on HIMSS Analytics’ resources, benchmarks, predictive models and assessment tools to improve decision making regarding their IT strategic roadmap and market strategy. HIMSS Analytics is uniquely positioned and differentiated through its industry focused offerings which include its Healthcare IT market intelligence tool, Healthcare IT insights and Healthcare IT benchmarks and services.  The LOGIC market intelligence tool has the largest technology data set with unmatched breadth and depth needed for guiding healthcare IT strategies.  HIMSS Analytics research and advisory consultants uncover unique insights on how to optimally use IT to tackle today’s healthcare challenges faced by both healthcare delivery organizations and IT companies.  Its EMR Adoption Model (EMRAM) provides a strategic roadmap and guidance along an 8-stage model with comparisons to healthcare organizations in the same country and around the world.

HIMSS Analytics, a wholly owned subsidiary of HIMSS, is the healthcare research and advisory firm for healthcare delivery organizations, IT companies, governmental entities, and financial, pharmaceutical, consulting and emerging technology solution partners worldwide. 

About The HCI Group

The HCI Group is a global leader in healthcare IT consulting with headquarters in Jacksonville, Fla. and international headquarters in the United Kingdom. It offers a broad scope of healthcare IT solutions in more than 10 countries from North America, Europe, Middle East, Asia and Australia, helping healthcare organizations plan, implement and sustain enterprise information technology systems.

Its services include enterprise IT system implementation and training, specialty service lines in optimization, clinical adoption, integration and testing, go-live and advisory services. The HCI Group’s clients include some of the finest healthcare providers in North America, as well as health systems in Europe, Middle East, Asia and Australia. Learn more about the HCI Group by visiting http://thehcigroup.com/.

Related Content

FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death
FDA issues Class I recall on insertion tubes after manufacturing error

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.